Corporate Presentation
Importance of nitric oxide, our pipeline, and our plans for market disruption.
-
Intratumoral Administration of High-Concentration Nitric Oxide and Anti PD-1 Treatment Leads to Higher Tumor Regression Rates and Prolonged Survival in CT26 Tumor-Bearing Mice – Society for Immunotherapy of Cancer (SITC) 2022 Annual Meeting
Hila Confino, David Greenberg, Selena Chaisson, Jedd Monson, Steve Lisi, Amir Avniel, Ido Wolf, Yana Epshtein • 11/10/2022 -
Characterization of Inhaled Nitric Oxide (iNO) for the treatment of Viral Community Acquired Pneumonia (VCAP)
T. Wolak, et al. • October 22, 2022 -
Home-based Treatment of Nontuberculous Mycobacteria (NTM) Pulmonary Disease Via a Novel Nitric Oxide Generator and Delivery System
Rachel Thomson, MBBS PhD FRACP • October 15, 2022 -
Home-based Intermittent Inhaled High-Dose Nitric Oxide (NO) in Nontuberculous Mycobacterial Pulmonary Disease Using a Novel NO Generator and Delivery System is Safe and Well-Tolerated. American Thoracic Society Conference 2022
R. Thomson, et al. (2022) • May 13-18, 2022 -
Treatment of VCAP and COVID-19 With Inhaled Nitric Oxide Using A Novel Nitric Oxide Generator. 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) 2022
T. Wolak, et al. (2022) • April 23-26, 2022 -
Long-term effects of inhaled nitric oxide in infants with bronchiolitis (BRO) – a multi center study. Pediatric Academic Societies Meeting 2022 (PAS 2022)
A. Goldbart, et al. (2022) • April 21-25, 2022 -
Ultra-high concentrations of gaseous nitric oxide show rapid cytotoxic capabilities against colon, breast, pancreatic and other cancer cells in vitro. American Association for Cancer Research (AACR) Annual Meeting 2022
Confino H et al. (2022) • April 8 - 13, 2022 -
Single intra-tumoral injection of gaseous nitric oxide induces an adaptive immune response in a mouse CT-26 solid tumor model. American Association for Cancer Research (AACR) Annual Meeting 2022
Confino H et al. (2022) • April 8 - 13, 2022 -
Non-tuberculous mycobacteria (NTM) infection treated with intermittently inhaled high-dose nitric oxide. BMJ Case Rep.
Goldbart A et al. (2021) • October 28, 2021 -
Inhaled Nitric Oxide for the Treatment of COVID-19 and Other Viral Pneumonias in Adults. American Thoracic Society (ATS) 2021
Wolak T. et al (2021) • May 14-19, 2021